Ludwig Johns Hopkins team led by Tushar Nichakawade, Jiaxin Ge, Bert Vogelstein and Suman Paul has shown that an anti-TRBC1 antibody linked to a cancer drug can effect a cure in mouse models of human T cell cancers, for which few viable therapies exist. https://bit.ly/3vuq8Mr